Αρχική World News Postoperative Radioiodine Can Be Avoided in Patients with Low-Risk Differentiated Thyroid Cancer World News Postoperative Radioiodine Can Be Avoided in Patients with Low-Risk Differentiated Thyroid Cancer Από Ogkologos - 12 Αυγούστου, 2025 810 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the IoN study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR A 27-Year-Old Woman Passed Away. The Note She Wrote The Day... 19 Ιουνίου, 2019 ESMO Breast Cancer Congress 2023 17 Απριλίου, 2023 Airbrushed Magazines Hurt the Body Image of Young Women — Here’s... 19 Μαΐου, 2021 Holidays, Traditions and Grief 21 Δεκεμβρίου, 2020 Φόρτωση περισσοτέρων HOT NEWS EMA Recommends Granting a Conditional Marketing Authorisation for Ciltacabtagene Autoleucel Brain Cancer Cells Hijack Gene “On Switches” to Drive Tumor Growth GreaterGood Charities Provides Supplies and Support to People and Pets After... Pumpkin Season!